---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-077698"
form_type: "8-K/A"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:58:32.848594+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aditxt files amended 8-K with Evofem unaudited interim financials for H1 2025

## Summary
- Evofem H1 2025 revenue $5.67M, net loss $0.83M (unaudited).
- Pro forma combined net loss of $15.99M for six months ended June 30, 2025.
- Acquisition consideration: $116.5M total ($99.1M convertible preferred, $1.8M cash, $15.7M notes).
- Preliminary goodwill $134.6M; intangible asset (SOLOSEC) $4.7M with 16-year life.
- Merger consummation extended to Sept 30, 2025 per Fifth Amendment.

## SEC filing metadata
- accession: 0001213900-25-077698
- form_type: 8-K/A
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390025077698/0001213900-25-077698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390025077698/ea0253649-8ka_aditxt.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-077698
- JSON: https://secwatch.observer/filing/0001213900-25-077698.json
- Plain text: https://secwatch.observer/filing/0001213900-25-077698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.